Previous 10 | Next 10 |
SAN FRANCISCO, CA / ACCESSWIRE / May 23, 2019 / Vista Partners ("Vista") has published May 2019's FREE Macroeconomic & Investment Monthly Newsletter, "Trade War Jitters?". Vista's monthly newsletter contains macroeconomic views & investment considerations that center around Vista...
Atossa Genetics (NASDAQ: ATOS ): Q1 GAAP EPS of -$0.62. More news on: Atossa Genetics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SEATTLE, May 13, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (Nasdaq:ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast cancer and other breast conditions, today announced financial results for the quarter ended March 31, 2...
SAN FRANCISCO, CA / ACCESSWIRE / April 30, 2019 / Vista Partners ("Vista") has published April 2019's FREE Macroeconomic & Investment Monthly Newsletter, "The Digital Economy & World Markets." Vista's monthly newsletter contains macroeconomic views & investment considerations ...
Moxian (NASDAQ: MOXC ) -10% . More news on: Moxian, Inc., SandRidge Permian Trust, Bitauto Holdings Limited, Stocks on the move, , Read more ...
On April 23, ATOS stock was up nearly 30% ahead of today’s presentation by Atossa Genetics’ CEO Steven Quay at the Precision: Breast Cancer World R&D Summit in Boston. It’s now the day of the presentation, and yet, ATOS stock ended the day down nearly 10%. Here&...
Gainers: Tiziana Life Sciences (NASDAQ: TLSA ) +35% . Appliance Recycling Centers of America (NASDAQ: ARCI ) +24% . Travelzoo (NASDAQ: TZOO ) +18% . Socket Mobile (NASDAQ: SCKT ) +16% . AXT (NASDAQ: AXTI ) +15% . Atossa Genetics (NASDAQ: ATOS ) +12% . Brightcove (NASDAQ: BCOV )...
SEATTLE, April 25, 2019 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (NASDAQ: ATOS ), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions, announced that today Steven C. Quay, M.D., Ph.D., Atossa’...
Gainers: Atossa Genetics (NASDAQ: ATOS ) +28% . Immunic (NASDAQ: IMUX ) +22% . Akari Therapeutics (NASDAQ: AKTX ) +19% . Superconductor Technologies (NASDAQ: SCON ) +18% . X4 Pharmaceuticals (NASDAQ: XFOR ) +17% . Hasbro (NASDAQ: HAS ) +16% . Twitter (NYSE: TWTR ) +16% . Trova...
TrovaGene (NASDAQ: TROV ) +22% on positive onvansertib data . More news on: TrovaGene, Inc., Akari Therapeutics, Plc, Hasbro, Inc., Stocks on the move, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...